Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

OVID THERAPEUTICS INC (OVID)

84 + Investors. Track Smart Money conviction in OVID. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +6
Streak
2Q ▲
Buyers last Q
54%

Smart Money Signals — OVID

Based on 85 hedge funds · latest filing: 2025 Q4 · updated quarterly

📈

Buying streak — 2 quarters in a row

last 6Q
For 2 consecutive quarters, more hedge funds added OVID than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
85 hedge funds hold OVID right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
📶

Steady growth — +9% more funds vs a year ago

fund count last 6Q
+7 new funds entered over the past year (+9% YoY). Gradual, steady growth in institutional ownership is generally a healthy signal — not a speculative rush, but consistent conviction.
🟡

Slight buying edge — 54% buying

47 buying40 selling
Last quarter: 47 funds bought or added vs 40 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.
⚠️

Fewer new buyers each quarter (-6 vs last Q)

new funds entering per quarter
Funds opening this position for the first time: 11 → 17 → 26 → 20. Each quarter fewer new institutions are entering. This usually means most funds that wanted in are already in — the stock is well-known but the pool of potential new buyers is shrinking.
🔒

46% of holders stayed for 2+ years

■ 46% conviction (2yr+) ■ 24% medium ■ 31% new
39 out of 85 hedge funds have held OVID for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +169% but shares only +115% — price-driven

Value
+168%
Shares
+114%
Last quarter: the total dollar value of institutional holdings rose +169%, but actual share count only changed +115%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

12 → 11 → 17 → 26 → 20 new funds/Q
New funds entering each quarter: 11 → 17 → 26 → 20. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Deep conviction — 59% of holders stayed 2+ years

■ 59% veterans ■ 6% 1-2yr ■ 36% new
Of 90 current holders: 53 (59%) have held for over 2 years without selling. These are not momentum buyers — they have lived through drawdowns and stayed. A large veteran base acts as a stabilizing force during selloffs.
📋

Smaller funds dominant — 15% AUM from top-100

15% from top-100 AUM funds
24 of 85 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.
4.0
out of 10
Moderate Exit Risk
Exit risk score 4.0/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — OVID

In 2025 Q4, 47 hedge funds were net buyers of OVID (20 opened a new position, 27 added to an existing one), while 40 reduced or exited (26 trimmed, 14 sold completely) — a 54% buyer ratio, indicating a slight buying edge. Net buying has persisted for two consecutive quarters, a positive momentum signal. Net fund flow last quarter: +6 funds (more new holders than closures). Total institutional holders: 85.

Hedge Fund Ownership: OVID

How many hedge funds hold OVID — quarterly history vs. share price
Quarterly hedge fund ownership of OVID vs. share price

Market Analysis: OVID

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: OVID

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 0 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
0.6
/ 10
conviction
Hedge Fund Positioning: OVID
2026 Q1 Stats Unlock in 3 days 84 + Investors

Track Smart Money conviction in OVID. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2025 Q4) Prior (2025 Q3) Change
Funds Holding 84 78 7.69%
13F Shares 62M 29M 114.77%
Total Value $101M $38M 168.85%
New Positions 20 26 -6
Increased Positions 25 18 +7
Closed Positions 14 15 -1
Reduced Positions 24 22 +2
Total Calls 3 3 -
Total Puts 2 1 100.0%
PUT/CALL Ratio 0.67 0.33 Bullish

Statistics: OVID

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q1)

84 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in OVID. Verified SEC 13F-HR filings.

QUARTER:
Top 25 institutional holders of OVID — 2025 Q4 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Saturn V Capital Management LP 1.68% 4,166,666 $9.2M
2 Propel Bio Management, LLC 1.28% 921,457 $2.0M
3 Affinity Asset Advisors, LLC 1.22% 10,636,318 $23.6M
4 Blue Owl Capital Holdings LP 1.14% 1,904,666 $4.2M
5 Rosalind Advisors, Inc. 0.99% 1,107,994 $2.5M
6 SPHERA FUNDS MANAGEMENT LTD. 0.57% 1,622,828 $3.6M
7 Ikarian Capital, LLC 0.52% 2,894,704 $6.4M
8 Sio Capital Management, LLC 0.40% 1,252,381 $2.8M
9 Verdad Advisers, LP 0.38% 151,919 $337K
10 EVENTIDE ASSET MANAGEMENT, LLC 0.36% 9,916,911 $22.0M
11 RA CAPITAL MANAGEMENT, L.P. 0.25% 10,714,000 $23.8M
12 SILVERARC CAPITAL MANAGEMENT, LLC 0.23% 1,000,000 $2.2M
13 Velan Capital Investment Management LP 0.22% 160,000 $355K
14 TLS Advisors LLC 0.10% 18,858 —
15 Informed Momentum Co LLC 0.07% 270,298 $600K
16 Parkman Healthcare Partners LLC 0.05% 208,205 $462K
17 Stonepine Capital Management, LLC 0.04% 40,000 $89K
18 BOOTHBAY FUND MANAGEMENT, LLC 0.03% 927,913 $2.1M
19 Diametric Capital, LP 0.02% 43,262 $96K
20 AXQ CAPITAL, LP 0.02% 85,411 $190K
21 ADAGE CAPITAL PARTNERS GP, L.L.C. 0.02% 6,163,781 $13.7M
22 GSA CAPITAL PARTNERS LLP 0.02% 123,969 —
23 BALYASNY ASSET MANAGEMENT L.P. 0.02% 5,533,073 $12.3M
24 Abel Hall, LLC 0.01% 31,189 $69K
25 FEDERATED HERMES, INC. 0.01% 3,571,000 $7.9M
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — OVID THERAPEUTICS INC (OVID)

What does the Smart Money Trend signal show for OVID?

Buying streak — 2 quarters in a row: For 2 consecutive quarters, more hedge funds added OVID than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for OVID?

Slight buying edge — 54% buying: Last quarter: 47 funds bought or added vs 40 that reduced or exited. It's nearly a 50/50 split — some institutions are convinced, others are taking profits. This mixed picture is normal near price highs.

What is the fund quality score for OVID holders?

Smaller funds dominant — 15% AUM from top-100: 24 of 85 holders rank in the top 100 by AUM, but together hold only 15% of total institutional value. The stock is held primarily by smaller and mid-sized funds.

How long have hedge funds held OVID?

46% of holders stayed for 2+ years: 39 out of 85 hedge funds have held OVID for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.